Page 102 - Micron News Today

In a recent article published in the journal Science Translational Medicine, researchers showed that a novel, lab-engineered monoclonal antibody (mAb), adintrevimab conferred up to 50% protection against symptomatic coronavirus disease 2019 (COVID-19). Furthermore, it demonstrated this exceptional efficacy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naïve individuals even at titers as low as 1:30.

Semiconductor manufacturers worldwide are forecast to increase 300mm fab capacity to an all-time high of 9.6 million wafers per month in 2026, according to SEMI.

Researchers in the US examined the neutralization evasion and receptor affinity properties of SARS-CoV-2 Omicron BA.2.75 sub-variants.

MICRON TECHNOLOGY INC - CONTINUE TO SEE AI AS A SECULAR DRIVER OF DEMAND GROWTH IN THE DATA CENTER ... | March 28, 2023

Achieving technology milestones while cutting expenses and reducing supply BOISE, Idaho, March 28, 2023 -- Micron Technology, Inc. today announced results for its second quarter of fiscal 2023,... | March 28, 2023

Micron Technology Inc on Tuesday forecast third-quarter revenue would tumble nearly 60% from a year earlier but the steep drop was in line with Wall Street expectations and company executives painted... | March 28, 2023

Tax credits for chipmakers championed by Schumer would be available for projects starting by end of 2026

Micron Technology Inc on Tuesday forecast third-quarter revenue in line with Wall Street expectations, banking on steady demand for memory chip products from the fast-growing artificial... | March 28, 2023

Micron is seeing pressure on its business from high customer inventory and weak PC demand. But things improve from here.

MICRON TECHNOLOGY INC CEO SAYS THESE ARE EARLY STAGES OF GENERATIVE AI, AND AI TRENDS WILL DRIVE GREATER DEMAND FOR MEMORY AND STORAGE ... | March 28, 2023